Nilotinib does not significantly reduce imatinib OCT-1 activity in either cell lines or primary CML cells.
Posted by rob on May 21, 2010 under Uncategorized | 
Comments are off for this article
 |
Related Articles |
Nilotinib does not significantly reduce imatinib OCT-1 activity in either cell lines or primary CML cells.
Leukemia. 2010 Apr;24(4):855-7
Authors: Eadie L, Hughes TP, White DL
PMID: 20147980 [PubMed - indexed for MEDLINE]